Testing a mindfulness meditation mobile app for the treatment of sleep-related symptoms in adults with sleep disturbance: A randomized controlled trial.

The objective of this randomized controlled trial was to test whether a commercially available, mindfulness meditation mobile app, (i.e., Calm app), was effective in reducing fatigue (primary outcome), pre-sleep arousal, and daytime sleepiness (secondary outcomes) in adults with sleep disturbance (I...

Full description

Bibliographic Details
Main Authors: Jennifer L Huberty, Jeni Green, Megan E Puzia, Linda Larkey, Breanne Laird, Ana-Maria Vranceanu, Robert Vlisides-Henry, Michael R Irwin
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0244717
_version_ 1819007966452383744
author Jennifer L Huberty
Jeni Green
Megan E Puzia
Linda Larkey
Breanne Laird
Ana-Maria Vranceanu
Robert Vlisides-Henry
Michael R Irwin
author_facet Jennifer L Huberty
Jeni Green
Megan E Puzia
Linda Larkey
Breanne Laird
Ana-Maria Vranceanu
Robert Vlisides-Henry
Michael R Irwin
author_sort Jennifer L Huberty
collection DOAJ
description The objective of this randomized controlled trial was to test whether a commercially available, mindfulness meditation mobile app, (i.e., Calm app), was effective in reducing fatigue (primary outcome), pre-sleep arousal, and daytime sleepiness (secondary outcomes) in adults with sleep disturbance (Insomnia Severity Index Score >10) as compared to a wait-list control group. Associations between the use of the Calm app (i.e., adherence to the intervention) and changes in sleep quality was also explored in the intervention group only. Adults with sleep disturbance were recruited (N = 640). Eligible and consenting participants (N = 263) were randomly assigned to the intervention (n = 124) or a wait-list control (n = 139) group. Intervention participants were asked to meditate using the Calm app ≥10 minutes/day for eight weeks. Fatigue, daytime sleepiness, and pre-sleep arousal were assessed at baseline, mid- (4-weeks) and post-intervention (8-weeks) in both groups, whereas sleep quality was evaluated only in the intervention group. Findings from intent-to-treat analyses suggest the use of the Calm app for eight weeks significantly decreased daytime fatigue (p = .018) as well as daytime sleepiness (p = .003) and cognitive (p = .005) and somatic (p < .001) pre-sleep arousal as compared to the wait-list control group. Within the intervention group, use of the Calm app was associated with improvements in sleep quality (p < .001). This randomized controlled trial demonstrates that the Calm app can be used to treat fatigue, daytime sleepiness, and pre-sleep arousal in adults with sleep disturbance. Given that the Calm app is affordable and widely accessible, these data have implications for community level dissemination of a mobile app to improve sleep-related symptoms associated with sleep disturbance. Trial registration: ClinicalTrials.gov NCT04045275.
first_indexed 2024-12-21T00:32:58Z
format Article
id doaj.art-f9ab9b3c201440168171b987e610d744
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T00:32:58Z
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-f9ab9b3c201440168171b987e610d7442022-12-21T19:21:51ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01161e024471710.1371/journal.pone.0244717Testing a mindfulness meditation mobile app for the treatment of sleep-related symptoms in adults with sleep disturbance: A randomized controlled trial.Jennifer L HubertyJeni GreenMegan E PuziaLinda LarkeyBreanne LairdAna-Maria VranceanuRobert Vlisides-HenryMichael R IrwinThe objective of this randomized controlled trial was to test whether a commercially available, mindfulness meditation mobile app, (i.e., Calm app), was effective in reducing fatigue (primary outcome), pre-sleep arousal, and daytime sleepiness (secondary outcomes) in adults with sleep disturbance (Insomnia Severity Index Score >10) as compared to a wait-list control group. Associations between the use of the Calm app (i.e., adherence to the intervention) and changes in sleep quality was also explored in the intervention group only. Adults with sleep disturbance were recruited (N = 640). Eligible and consenting participants (N = 263) were randomly assigned to the intervention (n = 124) or a wait-list control (n = 139) group. Intervention participants were asked to meditate using the Calm app ≥10 minutes/day for eight weeks. Fatigue, daytime sleepiness, and pre-sleep arousal were assessed at baseline, mid- (4-weeks) and post-intervention (8-weeks) in both groups, whereas sleep quality was evaluated only in the intervention group. Findings from intent-to-treat analyses suggest the use of the Calm app for eight weeks significantly decreased daytime fatigue (p = .018) as well as daytime sleepiness (p = .003) and cognitive (p = .005) and somatic (p < .001) pre-sleep arousal as compared to the wait-list control group. Within the intervention group, use of the Calm app was associated with improvements in sleep quality (p < .001). This randomized controlled trial demonstrates that the Calm app can be used to treat fatigue, daytime sleepiness, and pre-sleep arousal in adults with sleep disturbance. Given that the Calm app is affordable and widely accessible, these data have implications for community level dissemination of a mobile app to improve sleep-related symptoms associated with sleep disturbance. Trial registration: ClinicalTrials.gov NCT04045275.https://doi.org/10.1371/journal.pone.0244717
spellingShingle Jennifer L Huberty
Jeni Green
Megan E Puzia
Linda Larkey
Breanne Laird
Ana-Maria Vranceanu
Robert Vlisides-Henry
Michael R Irwin
Testing a mindfulness meditation mobile app for the treatment of sleep-related symptoms in adults with sleep disturbance: A randomized controlled trial.
PLoS ONE
title Testing a mindfulness meditation mobile app for the treatment of sleep-related symptoms in adults with sleep disturbance: A randomized controlled trial.
title_full Testing a mindfulness meditation mobile app for the treatment of sleep-related symptoms in adults with sleep disturbance: A randomized controlled trial.
title_fullStr Testing a mindfulness meditation mobile app for the treatment of sleep-related symptoms in adults with sleep disturbance: A randomized controlled trial.
title_full_unstemmed Testing a mindfulness meditation mobile app for the treatment of sleep-related symptoms in adults with sleep disturbance: A randomized controlled trial.
title_short Testing a mindfulness meditation mobile app for the treatment of sleep-related symptoms in adults with sleep disturbance: A randomized controlled trial.
title_sort testing a mindfulness meditation mobile app for the treatment of sleep related symptoms in adults with sleep disturbance a randomized controlled trial
url https://doi.org/10.1371/journal.pone.0244717
work_keys_str_mv AT jenniferlhuberty testingamindfulnessmeditationmobileappforthetreatmentofsleeprelatedsymptomsinadultswithsleepdisturbancearandomizedcontrolledtrial
AT jenigreen testingamindfulnessmeditationmobileappforthetreatmentofsleeprelatedsymptomsinadultswithsleepdisturbancearandomizedcontrolledtrial
AT meganepuzia testingamindfulnessmeditationmobileappforthetreatmentofsleeprelatedsymptomsinadultswithsleepdisturbancearandomizedcontrolledtrial
AT lindalarkey testingamindfulnessmeditationmobileappforthetreatmentofsleeprelatedsymptomsinadultswithsleepdisturbancearandomizedcontrolledtrial
AT breannelaird testingamindfulnessmeditationmobileappforthetreatmentofsleeprelatedsymptomsinadultswithsleepdisturbancearandomizedcontrolledtrial
AT anamariavranceanu testingamindfulnessmeditationmobileappforthetreatmentofsleeprelatedsymptomsinadultswithsleepdisturbancearandomizedcontrolledtrial
AT robertvlisideshenry testingamindfulnessmeditationmobileappforthetreatmentofsleeprelatedsymptomsinadultswithsleepdisturbancearandomizedcontrolledtrial
AT michaelrirwin testingamindfulnessmeditationmobileappforthetreatmentofsleeprelatedsymptomsinadultswithsleepdisturbancearandomizedcontrolledtrial